Cameron John Reynolds Volitionrx LTD (VNRX) insider trading activity

Cameron John Reynolds is President and CEO of VOLITIONRX LTD. Currently has a direct ownership of 2.61 Million shares of VNRX, which is worth approximately $1.64 Million. The most recent transaction as insider was on Aug 05, 2025, when has been sold 78,125 shares (Common Stock) at a price of $0.64 per share, resulting in proceeds of $50,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.61M

13.51% 3M change

39.24% 12M change

Total Value Held $1.64 Million

Cameron John Reynolds Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2025	BUY Open market or private purchase	$50,000 $0.64 p/Share	78,125 Added 2.91%	2,609,847 Common Stock
Jul 24 2025	BUY Grant, award, or other acquisition	-	200,000 Added 7.32%	2,531,722 Common Stock
Jun 12 2025	BUY Open market or private purchase	$7,375 $0.59 p/Share	12,500 Added 0.53%	2,331,722 Common Stock
May 19 2025	BUY Open market or private purchase	$8,800 $0.44 p/Share	20,000 Added 0.85%	2,319,222 Common Stock
Mar 26 2025	BUY Open market or private purchase	$99,999 $0.55 p/Share	181,818 Added 7.33%	2,299,222 Common Stock
Dec 09 2024	BUY Open market or private purchase	$79,692 $0.57 p/Share	139,811 Added 6.19%	2,117,404 Common Stock
Sep 01 2024	BUY Grant, award, or other acquisition	-	103,243 Added 4.96%	1,977,593 Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	29,500 Added 1.55%	1,874,350 Common Stock
Jun 01 2024	BUY Grant, award, or other acquisition	-	90,182 Added 4.66%	1,844,850 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	50,150 Added 2.78%	1,754,668 Common Stock
Dec 08 2023	BUY Open market or private purchase	$6,700 $0.67 p/Share	10,000 Added 0.58%	1,704,518 Common Stock
Oct 19 2023	BUY Grant, award, or other acquisition	-	200,000 Added 10.56%	1,694,518 Common Stock
Aug 16 2023	BUY Open market or private purchase	$12,200 $1.22 p/Share	10,000 Added 0.66%	1,494,518 Common Stock
Jul 05 2023	BUY Grant, award, or other acquisition	-	40,050 Added 2.63%	1,484,518 Common Stock
Jan 12 2023	BUY Grant, award, or other acquisition	-	33,375 Added 2.26%	1,444,468 Common Stock
Oct 13 2022	BUY Grant, award, or other acquisition	-	15,575 Added 1.09%	1,411,093 Common Stock
Oct 04 2022	BUY Grant, award, or other acquisition	-	200,000 Added 12.54%	1,395,518 Common Stock
Aug 30 2022	BUY Open market or private purchase	$5,635 $1.61 p/Share	3,500 Added 0.29%	1,195,518 Common Stock
Jun 23 2022	BUY Grant, award, or other acquisition	-	32,270 Added 2.64%	1,192,018 Common Stock
Apr 07 2022	BUY Grant, award, or other acquisition	-	17,375 Added 1.48%	1,159,748 Common Stock

CJR

Cameron John Reynolds

President and CEO

Henderson, NV

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Value

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX

Account